Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Withdrawn Phase 2 Interventional

S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer

ClinicalTrials.gov ID: NCT00217659

Public ClinicalTrials.gov record NCT00217659. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 7:59 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Study of Goserelin Plus Anastrozole for the Treatment of Male Patients With Hormone-Receptor Positive Metastatic or Recurrent Breast Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using goserelin and anastrozole may fight breast cancer by blocking the use of estrogen by the tumor cells. Giving goserelin together with anastrozole may be an effective treatment for male breast cancer. PURPOSE: This phase II trial is studying how well giving goserelin together with anastrozole works in treating men with recurrent or metastatic breast cancer.

Study identification

NCT ID
NCT00217659
Recruitment status
Withdrawn
Study type
Interventional
Phase
Phase 2
Lead sponsor
SWOG Cancer Research Network
Network
Enrollment
Not listed

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2005 (Type not available)
Primary completion
Jan 2007 (Actual)
Completion
Jan 2007 (Actual)
Last update posted
Jan 3, 2013

2005 – 2007

United States locations

U.S. sites
57
U.S. states
13
U.S. cities
39
Facility City State ZIP Site status
USC/Norris Comprehensive Cancer Center and Hospital Los Angeles California 90089-9181 —
University of California Davis Cancer Center Sacramento California 95817 —
University of Colorado Cancer Center at UC Health Sciences Center Aurora Colorado 80045 —
Veterans Affairs Medical Center - Denver Denver Colorado 80220 —
Montrose Memorial Hospital Cancer Center Montrose Colorado 81401 —
Exempla Lutheran Medical Center Wheat Ridge Colorado 80033 —
Broward General Medical Center Cancer Center Fort Lauderdale Florida 33316 —
Curtis & Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center Savannah Georgia 31403-3089 —
Decatur Memorial Hospital Cancer Care Institute Decatur Illinois 62526 —
Regional Cancer Center at Memorial Medical Center Springfield Illinois 62781-0001 —
Cancer Center of Kansas, PA - Chanute Chanute Kansas 66720 —
Cancer Center of Kansas, PA - Dodge City Dodge City Kansas 67801 —
Cancer Center of Kansas, PA - El Dorado El Dorado Kansas 67042 —
Cancer Center of Kansas, PA - Kingman Kingman Kansas 67068 —
Southwest Medical Center Liberal Kansas 67901 —
Cancer Center of Kansas, PA - Newton Newton Kansas 67114 —
Cancer Center of Kansas, PA - Parsons Parsons Kansas 67357 —
Cancer Center of Kansas, PA - Pratt Pratt Kansas 67124 —
Cancer Center of Kansas, PA - Salina Salina Kansas 67042 —
Tammy Walker Cancer Center at Salina Regional Health Center Salina Kansas 67401 —
Cancer Center of Kansas, PA - Wellington Wellington Kansas 67152 —
Associates in Womens Health, PA - North Review Wichita Kansas 67203 —
Cancer Center of Kansas, PA - Medical Arts Tower Wichita Kansas 67208 —
Cancer Center of Kansas, PA - Wichita Wichita Kansas 67214 —
CCOP - Wichita Wichita Kansas 67214 —
Via Christi Cancer Center at Via Christi Regional Medical Center Wichita Kansas 67214 —
Cancer Center of Kansas, PA - Winfield Winfield Kansas 67156 —
Josephine Ford Cancer Center at Henry Ford Hospital Detroit Michigan 48202 —
CCOP - Cancer Research for the Ozarks Springfield Missouri 65802 —
St. John's Regional Health Center Springfield Missouri 65804 —
CCOP - Montana Cancer Consortium Billings Montana 59101 —
Hematology-Oncology Centers of the Northern Rockies - Billings Billings Montana 59101 —
Northern Rockies Radiation Oncology Center Billings Montana 59101 —
St. Vincent Healthcare Billings Montana 59101 —
Billings Clinic Cancer Center Billings Montana 59107-5100 —
Deaconess Billings Clinic - Downtown Billings Montana 59107-7000 —
Bozeman Deaconess Hospital Bozeman Montana 59715 —
St. James Community Hospital Butte Montana 59701 —
Great Falls Clinic Great Falls Montana 59405 —
Not listed Great Falls Montana 59405 —
St. Peter's Hospital Helena Montana 59601 —
Glacier Oncology, PLLC Kalispell Montana 59901 —
Kalispell Medical Oncology Kalispell Montana 59901 —
Kalispell Regional Medical Center Kalispell Montana 59901 —
Community Medical Center Missoula Montana 59801 —
Guardian Oncology and Center for Wellness Missoula Montana 59804 —
Montana Cancer Specialists at Montana Cancer Center Missoula Montana 59807-7877 —
Montana Cancer Center at St. Patrick Hospital and Health Sciences Center Missoula Montana 59807 —
Wayne Memorial Hospital, Incorporated Goldsboro North Carolina 27534 —
Rutherford Hospital Rutherfordton North Carolina 28139 —
Cleveland Clinic Taussig Cancer Center Cleveland Ohio 44195 —
Community Oncology Group at Cleveland Clinic Cancer Center Independence Ohio 44131 —
Cleveland Clinic - Wooster Wooster Ohio 44691 —
AnMed Health Cancer Center Anderson South Carolina 29621 —
CCOP - Upstate Carolina Spartanburg South Carolina 29303 —
Gibbs Regional Cancer Center at Spartanburg Regional Medical Center Spartanburg South Carolina 29303 —
Welch Cancer Center at Sheridan Memorial Hospital Sheridan Wyoming 82801 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00217659, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 3, 2013 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00217659 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →